These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11253612)

  • 1. A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.
    Oliver RE; Jones AF; Rowland M
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):27-55. PubMed ID: 11253612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.
    Blakey GE; Nestorov IA; Arundel PA; Aarons LJ; Rowland M
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):277-312. PubMed ID: 9474530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions.
    Xia B; Heimbach T; Lin TH; He H; Wang Y; Tan E
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1567-82. PubMed ID: 22526410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.
    Oliver RE; Heatherington AC; Jones AF; Rowland M
    J Pharmacokinet Biopharm; 1997 Aug; 25(4):389-412. PubMed ID: 9561486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of a single adjusting compartment: a novel methodology for whole body physiologically-based pharmacokinetic modelling.
    Ando H; Izawa S; Hori W; Nakagawa I
    Theor Biol Med Model; 2008 Aug; 5():19. PubMed ID: 18687151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.
    Schwab AJ; Geng W; Pang KS
    J Pharmacokinet Biopharm; 1998 Apr; 26(2):163-81. PubMed ID: 9795880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
    Berezhkovskiy LM
    J Pharm Sci; 2016 Aug; 105(8):2453-8. PubMed ID: 27290628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
    Graf JF; Scholz BJ; Zavodszky MI
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):37-54. PubMed ID: 22161221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
    Berezhkovskiy LM
    J Pharm Sci; 2010 Jan; 99(1):475-85. PubMed ID: 19492340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution and physiologically based pharmacokinetics of antisense phosphorothioate oligonucleotide ISIS 1082 in rat.
    Peng B; Andrews J; Nestorov I; Brennan B; Nicklin P; Rowland M
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):15-27. PubMed ID: 11258618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.
    Roberts MS; Anissimov YG
    J Pharmacokinet Biopharm; 1999 Aug; 27(4):343-82. PubMed ID: 10826128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a generic physiologically based pharmacokinetic model for children.
    Edginton AN; Schmitt W; Willmann S
    Clin Pharmacokinet; 2006; 45(10):1013-34. PubMed ID: 16984214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
    Poulin P; Theil FP
    J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
    Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
    J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Taylor dispersion in pharmacokinetic and multiple indicator dilution modelling.
    Fallon MS; Howell BA; Chauhan A
    Math Med Biol; 2009 Dec; 26(4):263-96. PubMed ID: 19318591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compartment simulation models and physiologic use in pharmaco- and toxicokinetics].
    Kostrzewski P
    Med Pr; 1998; 49(1):83-92. PubMed ID: 9587914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to physiologically-based pharmacokinetic models.
    Upton RN; Foster DJ; Abuhelwa AY
    Paediatr Anaesth; 2016 Nov; 26(11):1036-1046. PubMed ID: 27550716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.